We're experiencing a higher volume of calls and emails than usual and will get back to you as soon as we can. We appreciate your patience.
For the latest advice on COVID-19, please visit our dedicated information hub.
documents

Melflufen Horizons Infosheet

This Horizons Infosheet contains information about melflufen (Ygalo®), a drug being investigated for the treatment of myeloma.

Last updated: December 2019
Review date: June 2020